HUAREN MEDICAL TECHNOLOGY
NEWS
Company News
08
2022-06
On the afternoon of June 2, 2022, Cao Yanbin, former director of Guangxi Sports Hospital and honorary vice chairman of the Sports Medicine Branch of the Chinese Society of Traditional Chinese Medicine, together with the relevant persons in charge of the Committee for the Management of Middle-aged and Elderly Diseases of the China Association for the Promotion of Anti-Aging and the Affiliated Tumor Hospital of Guangxi Medical University, went to the Guangxi Academy of Sciences Institute of Medicine and Health, and the Joint Experimental Center of Huaren Medical Science and Technology Group for a visit to investigate and research, and the president of the hospital, Ji Feng, and others accompanied the whole process.
View More28
2022-05
Mesenchymal Stem Cells Prevent Side Effects of Cancer Immunotherapy
Immune checkpoint inhibitors (ICIs), the stars of the anticancer world, have shown excellent efficacy in the treatment of a variety of cancers and have brought new hope to many cancer patients since their inception. However, like other anti-tumour drugs, ICIs, while exerting anti-tumour effects, are also associated with the occurrence of immunotherapy-associated adverse events (irAE), which may cause side effects such as autoimmune diseases, and one of the serious side effects is that they may lead to the development of type 1 diabetes mellitus.
View More21
2022-05
On the afternoon of May 15, 2022, the docking meeting of the innovative biomedical industrial park project of Huaiyang District, Zhoukou City was held in the Standing Committee Room on the third floor of the District Committee. Zhoukou Huaiyang District Party Committee Secretary Zhang Jiandang and other leaders and Guangxi Huaren Medical Science and Technology Group President Ji Feng attended the meeting.
View More21
2022-05
On May 20, 2022, the first "Open Day" activity was successfully held in the laboratory of Guangxi Academy of Sciences Institute of Medicine and Health, which is located in Building 3, Phase II, Big Data Industrial Park, No. 9, Haihui Road, Nanning Area, China (Guangxi) Pilot Free Trade Zone.
View More13
2022-05
Mesenchymal stem cells combined with filipin protein bioscaffolds - a new hope for tendon repair!
Tendons transmit force from muscle to bone and are an important connective tissue in the human body. Often the mention of tendon injuries brings a big frown to people's faces: in most people's perception, the first time they probably learnt about tendon injuries was at the 2008 Olympic Games in China, when the Chinese athlete Liu Xiang regrettably retired because of a ruptured Achilles tendon.
View More08
2022-05
Tumour-infiltrating T cells possess special access to the interior of the tumour
Immune checkpoint blockade therapy is a treatment that has the potential to completely cure cancer, and although this intervention has shown considerable efficacy in patients with metastatic melanoma, clinical efficacy remains low for most other cancers, a condition that is associated with tumours and lymphocytes, including stem-cell-like tumour-infiltrating T-cells as well as T-cells that express inhibitory receptors (e.g. PD-1).
View MoreSUBSCRIPTION INFORMATION
We will send you real-time information regularly!
Guangxi Huaren Medical Technology Group Co., Ltd.
Tel: 400-138-8669/ 0771-611-0603
Address: 15th Floor, Building A, Biyuan Center, Wuxiang New District, Nanning City, China (Guangxi) Pilot Free Trade Zone
Huaren Medical Technology
Huaren Medical Research
Hua Ren Cell said